Pupillometric findings in ATTRv patients and carriers: results from a single-centre experience

References

• Planté-Bordeneuve V, Said G. Familial amyloid polyneuropathy. Lancet Neurol. 2011;10(12):1086–1097.
   PubMed Web of Science ®Google Scholar
• Adams D, Koike H, Slama M, et al. Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease. Nat Rev Neurol. 2019;15(7):387–404.
   PubMed Web of Science ®Google Scholar
• Luigetti M, Romano A, Di Paolantonio A, et al. Diagnosis and treatment of Hereditary Transthyretin Amyloidosis (hATTR) polyneuropathy: current perspectives on improving patient care. Ther Clin Risk Manag. 2020;16:109–123.
   PubMed Web of Science ®Google Scholar
• Manganelli F, Fabrizi GM, Luigetti M, et al. Hereditary transthyretin amyloidosis overview. Neurol Sci. 2020. Epub ahead of print. doi: 10.1007/s10072-020-04889-2.
   Web of Science ®Google Scholar
• Minnella AM, Rissotto R, Antoniazzi E, et al. Ocular involvement in hereditary amyloidosis. Genes (Basel). 2021;12(7):955.
   PubMed Web of Science ®Google Scholar
• Ferraro PM, D’Ambrosio V, Di Paolantonio A, et al. Renal involvement in hereditary transthyretin amyloidosis: an Italian single-Centre experience. Brain Sci. 2021;11(8):980.
   PubMed Web of Science ®Google Scholar
• Luigetti M, Tortora A, Romano A, et al. Gastrointestinal manifestations in hereditary transthyretin amyloidosis: a single-centre experience. J Gastrointestin Liver Dis. 2020;29(3):339–343.
   PubMed Web of Science ®Google Scholar
• Waddington-Cruz M, Wixner J, Amass L, et al. Characteristics of patients with late- vs. early-onset Val30Met transthyretin amyloidosis from the Transthyretin Amyloidosis Outcomes Survey (THAOS). Neurol Ther. 2021;10(2):753–766.
   PubMed Web of Science ®Google Scholar
• Andrade C. A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves. Brain. 1952;75(3):408–427.
   PubMed Web of Science ®Google Scholar
• Russo M, Obici L, Bartolomei I, et al. ATTRv amyloidosis Italian Registry: clinical and epidemiological data. Amyloid. 2020;27(4):259–265.
   PubMed Web of Science ®Google Scholar
• Luigetti M, Guglielmino V, Antonini G, et al. ATTRv in Lazio-Italy: a high-prevalence region in a non-endemic country. Genes (Basel). 2021;12(6):829.
   PubMed Web of Science ®Google Scholar
• Planté-Bordeneuve V, Kerschen P. Transthyretin familial amyloid polyneuropathy. In: Handbook of clinical neurology. Amsterdam, The Netherlands: Elsevier; 2013. p. 643–658.
   Google Scholar
• Conceição I, Damy T, Romero M, et al. Early diagnosis of ATTR amyloidosis through targeted follow-up of identified carriers of TTR gene mutations. Amyloid. 2019;26(1):3–9.
   PubMed Web of Science ®Google Scholar
• Haraoka K, Ando Y, Ando E, et al. Amyloid deposition in ocular tissues of patients with familial amyloidotic polyneuropathy (FAP). Amyloid. 2002;9(3):183–189.
   PubMed Web of Science ®Google Scholar
• Martins AC, Rosa AM, Costa E, et al. Ocular manifestations and therapeutic options in patients with familial amyloid polyneuropathy: a systematic review. Biomed Res Int. 2015;2015:282405.
   PubMed Web of Science ®Google Scholar
• Reynolds MM, Veverka KK, Gertz MA, et al. Ocular manifestations of familial transthyretin amyloidosis. Am J Ophthalmol. 2017;183:156–162.
   PubMed Web of Science ®Google Scholar
• Larson MD, Behrends M. Portable infrared pupillometry: a review. Anesth Analg. 2015;120(6):1242–1253.
   PubMed Web of Science ®Google Scholar
• Ferrari GL, Marques JLB, Gandhi RA, et al. Using dynamic pupillometry as a simple screening tool to detect autonomic neuropathy in patients with diabetes: a pilot study. Biomed Eng Online. 2010;9:26.
   PubMed Web of Science ®Google Scholar
• Giza E, Fotiou D, Bostantjopoulou S, et al. Pupil light reflex in Parkinson’s disease: evaluation with pupillometry. Int J Neurosci. 2011;121(1):37–43.
   PubMed Web of Science ®Google Scholar
• Chen J, Gombart Z, Rogers S, et al. Pupillary reactivity as an early indicator of increased intracranial pressure: the introduction of the neurological pupil index. Surg Neurol Int. 2011;2:82.
   PubMedGoogle Scholar
• Lussier BL, Stutzman SE, Atem F, et al. Distributions and reference ranges for automated pupillometer values in neurocritical care patients. J Neurosci Nurs. 2019;51(6):335–340.
   PubMed Web of Science ®Google Scholar
• Bellavia S, Scala I, Luigetti M, et al. Instrumental evaluation of COVID-19 related dysautonomia in non-critically-ill patients: an observational, cross-sectional study. JCM. 2021;10(24):5861.
   Google Scholar
• Marques JH, Malheiro L, Malheiro J, et al. Pupillometry: An objective test to assess endocular hereditary transthyretin amyloidosis. Eur J Ophthalmol. 2022;32(1):637–642.
   PubMed Web of Science ®Google Scholar
• Luigetti M, Bisogni G, Romano A, et al. Sudoscan in the evaluation and follow-up of patients and carriers with TTR mutations: experience from an Italian Centre. Amyloid. 2018;25(4):242–246.
   PubMed Web of Science ®Google Scholar
• Primiano G, Verdolotti T, D’Apolito G, et al. Muscle MRI as a useful biomarker in hereditary transthyretin amyloidosis: a pilot study. Genes (Basel). 2021;12(11):1786.
   PubMed Web of Science ®Google Scholar
• Luigetti M, Di Paolantonio A, Guglielmino V, et al. Neurofilament light chain as a disease severity biomarker in ATTRv: data from a single-centre experience. Neurol Sci. 2022;43(4):2845–2848.
   PubMed Web of Science ®Google Scholar
• Kakihara S, Hirano T, Imai A, et al. Comments on pupillometry: an objective test to assess endocular hereditary transthyretin amyloidosis. Eur J Ophthalmol. 2022;32(1):NP332–NP333.
   PubMed Web of Science ®Google Scholar
• Denier C, Ducot B, Husson H, et al. A brief compound test for assessment of autonomic and sensory-motor dysfunction in familial amyloid polyneuropathy. J Neurol. 2007;254(12):1684–1688.
   PubMed Web of Science ®Google Scholar
• Sletten DM, Suarez GA, Low PA, et al. COMPASS 31: a refined and abbreviated Composite Autonomic Symptom Score. Mayo Clin Proc. 2012;87(12):1196–1201.
   PubMed Web of Science ®Google Scholar
• Adams D, Algalarrondo V, Polydefkis M, et al. Expert opinion on monitoring symptomatic hereditary transthyretin-mediated amyloidosis and assessment of disease progression. Orphanet J Rare Dis. 2021;16(1):411.
   PubMed Web of Science ®Google Scholar